Davol INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$27Mgeneral payments (2019-2025)
$903Kresearch payments (2019-2025)
26,490clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Phasix Mesh $2.3M associated (2023-2025)
- Arista Ah Flexitip $503K associated (2023-2025)
- Arista $345K associated (2023-2025)
- Progel Applicator Spray Tips $146K associated (2023-2025)
- Channel Drain $45K associated (2023-2025)
- Surgiphor $38K associated (2023-2025)
- V. Mueller $30K associated (2023-2025)
- Bard 3dmax Mesh $17K associated (2023-2025)
- Bard Crurasoft Patch $16K associated (2023-2025)
- Tridyne Vascular Sealant $9,052 associated (2023-2025)
- Avitene Ultrafoam $7,737 associated (2023-2025)
- Ventralight St $3,741 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Robert Rehnke | St Petersburg, FL | Plastic Surgery | $6,053,539.88 |
| John Fischer | Philadelphia, PA | Plastic Surgery | $2,398,761.42 |
| Javad Parvizi | Philadelphia, PA | Adult Reconstructive Orthopaedic Surgery | $853,142.38 |
| John Roth | Lexington, KY | Surgery | $711,814.97 |
| Stephen Kovach | Philadelphia, PA | Plastic Surgery | $570,909.79 |
| Steven Demeester | Portland, OR | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $532,159.21 |
| Ara Klijian | Murrieta, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $408,295.59 |
| Rasa Zarnegar | New York, NY | Surgery | $397,058.13 |
| Bruce Van Natta | Indianapolis, IN | $387,108.95 | |
| Kristopher Lybarger | Kansas City, MO | Gynecologic Oncology | $342,921.46 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.